Dovie L. Watson, MD, MSCE
Assistant Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
Affiliated Faculty, Penn Eidos LGBTQ+ Health Initiative, University of Pennsylvania
Department: Medicine
Contact information
3400 Spruce St
3 Silverstein, Suite E
Philadelphia, PA 19104
3 Silverstein, Suite E
Philadelphia, PA 19104
Office: 267-593-0299
Fax: 607-333-9682
Lab: 267-662-6932
Fax: 607-333-9682
Lab: 267-662-6932
Publications
Education:
BA (Biological Sciences; Feminist, Gender, and Sexuality Studies)
Cornell University, 2008.
MD
Northwestern University Feinberg School of Medicine, 2014.
MSCE
University of Pennsylvania Perelman School of Medicine, 2020.
Permanent linkBA (Biological Sciences; Feminist, Gender, and Sexuality Studies)
Cornell University, 2008.
MD
Northwestern University Feinberg School of Medicine, 2014.
MSCE
University of Pennsylvania Perelman School of Medicine, 2020.
Description of Clinical Expertise
HIV prevention and treatment; PrEP care; STI diagnosis and treatment; sexual health; LGBTQ+ health; integrated gender affirming medical care including hormone managementDescription of Research Expertise
HIV prevention and treatment outcomes; LGBTQ+ health; health equity in HIV prevention care continuum outcomes among Black and Latinx LGBTQ+ populationsSelected Publications
Bonett S, Sweeney A, Li Q, Watson DL, Bauermeister J, Hernandez B, Williams J, Brady KA: Facilitators and barriers to equitable implementation of telehealth PrEP delivery: A qualitative descriptive study of program staff and stakeholders. Health Promot Pract 19, Jun 2025.Watson DL, Bonett S, Meanley S, Wood SM, Brady KA, Bauermeister JA: Acceptability and feasibility of HIV self-testing integration into publicly-funded HIV prevention services: Perspectives from HIV testing agency staff that provide HIV testing services to sexual and gender minority youth in Philadelphia County. PLoS One 20(3), Mar 2025.
Meanley S, Listerud L, Kosciow B, Richards A, Bauermeister JA, Watson DL, Hiserodt E, Rocha D, Parchment A, Arnold E, Bouris A: Overcoming salient barriers to PrEP use among Black and Latino cisgender men who have sex with men: Provider and patient perspectives on patient-centered PrEP care. American Academy of Health Behavior 2025 Scientific Meeting Mar 2025.
Watson DL, Listerud L, Drab R, Lin WL, Momplaisir F, Bauermeister JA: HIV PrEP Method Preferences Among Transgender and Gender-Diverse Adults in the United States. Conference on Retroviruses and Opportunistic Infections Mar 2025.
Watson DL, Richmond J, Desai AN: Racial Inequity and Structural Barriers to COVID-19 Services. JAMA Netw Open 8(7), 2025.
Watson DL: Burnout Among Sexual and Gender Minority Physicians—From Recognition to Intervention JAMA Netw Open 7(11), Nov 2024.
Poteat T, Beauchamp G, Marzinke MA, Gomez-Feliciano K, Akingbade B, Beck J, Bell I, Cummings V, Emel L, Franks J, Jalil EM, Lake JE, Liu A, Lucas J, Mayer KH, Radix AE, Rooney J, Spiegel H, Watson DL, Zangeneh S, Reisner SL, HPTN 091 Study Team.: PrEP uptake and adherence among transgender women: findings from a randomized clinical trial of a multicomponent intervention (HPTN 091). HIVR4P 2024, Fifth HIV Research and Prevention Conference Oct 2024.
Watson DL, Listerud L, Drab RA, Lin WY, Momplaisir F, Bauermeister JA: Demographic and behavioral characteristics of sexually active, HIV-negative transgender and gender-diverse adults in the United States interested in HIV pre-exposure prophylaxis initiation. AIDS 2024, the 26th International AIDS Conference Jul 2024.
Bauermeister JA, Choi SK, Aryal S, Lin WY, Golinkoff J, Hirshfield S, Mulawa MI, Watson DL, Hightow-Weidman LB, Muessig KE: HealthMPowerment (HMP) Stigma: digital intervention increases undetectable viral load among Young Black and Latinx MSM and Transgender women living with HIV. AIDS 2024, the 26th International AIDS Conference Jul 2024.
Vulakh G, Listerud L, Lin WY, Momplaisir F, Bauermeister JA, Watson DL: Factors associated with increased HIV pre-exposure prophylaxis (PrEP) stigma among sexually active, HIV-negative transgender and gender-diverse adults in the United States. AIDS 2024, the 26th International AIDS Conference Jul 2024.